LAMA2-related Muscular Dystrophy Brain Study
Maneno muhimu
Kikemikali
Maelezo
LAMA2-MD is a congenital muscular dystrophy (CMD) subtype caused by mutations in the laminin alpha 2 gene. LAMA2-MD may present clinically as an early onset, severe phenotype or a late onset limb girdle phenotype. The early onset form is most commonly associated with a complete absence of merosin on muscle biopsy with profound neonatal hypotonia, possible respiratory distress and feeding difficulties while the late onset form presents with proximal muscle weakness, contractures and is able to achieve walking. In both early and late onset forms, brain white matter abnormalities have been described on brain MRI and approximately 8-30% develop a seizure disorder. On magnetic resonance (MR) spectroscopy, white matter changes are shown to be due to increased water content rather than areas of demyelination. Both, non-ambulant and ambulant patients may develop respiratory insufficiency requiring non-invasive ventilation and scoliosis.
Although several studies have evaluated the correlation between brain MRI white matter changes and cognition, no studies to date have provided a systematic evaluation of brain imaging, electrophysiologic testing and seizures in patients identified by molecular or immunohistochemical testing to have LAMA2-MD.
Tarehe
Imethibitishwa Mwisho: | 09/30/2015 |
Iliyowasilishwa Kwanza: | 09/18/2013 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 09/23/2013 |
Iliyotumwa Kwanza: | 09/26/2013 |
Sasisho la Mwisho Liliwasilishwa: | 03/04/2018 |
Sasisho la Mwisho Lilichapishwa: | 03/06/2018 |
Tarehe halisi ya kuanza kwa masomo: | 10/31/2013 |
Tarehe ya Kukamilisha Msingi iliyokadiriwa: | 10/31/2014 |
Tarehe ya Kukamilisha Utafiti: | 11/30/2014 |
Hali au ugonjwa
Awamu
Vigezo vya Kustahiki
Jinsia Inastahiki Kujifunza | All |
Njia ya sampuli | Non-Probability Sample |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: - Genetic confirmation of 2 variants in LAMA2 gene OR muscle biopsy with complete absence of merosin - Complete authorization to obtain medical records for Congenital Muscle Disease International Registry - Complete authorization to obtain medical records for National Institutes of Health (NIH) - Reside in United States or Canada - Complete registration and intake survey in the Congenital Muscle Disease International Registry Exclusion Criteria: - Individuals with LAMA2-MD who have not had a brain MRI |
Matokeo
Hatua za Matokeo ya Msingi
1. Identify and grade the structural brain abnormalities observed on MRI [up to 5 months]
Hatua za Matokeo ya Sekondari
1. Seizure History [up to 8 months]
2. Evaluation of baseline and diagnostic electroencephalograms [up to 8 months]
3. Examine the association between brain MRI structural abnormalities and EEG findings [up to 11 months]